Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs CERo Therapeutics Holdings, Inc. (CERO)

Biodexa Pharmaceuticals PLC Unsponsored ADR and CERo Therapeutics Holdings, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $700.0K against $140.0K — 5.0× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. CERo Therapeutics Holdings, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, CERo Therapeutics Holdings, Inc. leads on 6 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 3.

Valuation

Metric BDRX CERO Biotechnology median
P/E n/m 0.00 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 n/m 0.74
EV/Sales (2.81) n/m 10.73
Earnings yield (375.47%) 300,221.00% (28.84%)
Free cash flow yield 0.00% (2,869.14%) (23.03%)

Profitability

Metric BDRX CERO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 453.76% (57.72%)
Return on assets 0.00% (2,352.32%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDRX CERO Biotechnology median
Revenue growth (TTM) 60.22% — 5.64%
EPS growth (last fiscal year) 89.68% 92.12% —
Revenue growth, 5-year CAGR (28.78%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX CERO Biotechnology median
Debt to equity 0.00 (0.02) 0.00
Current ratio 2.41 0.05 4.73
Net debt to EBITDA 1.00 0.10 0.96

Dividend

Metric BDRX CERO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BDRX CERO Biotechnology median
Market cap 700.00k 140.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack